Affiliated to research
In 1996 I received my medical degree in medicine in Tabriz, Iran. After my graduation I started to work in the field of public health where I among other tasks was responsible for visiting patients and leading an expert group for implementing vaccination-programs and assisting the pregnant women and elderly that were in need of an increased care. After spending seven years working in this field, I eagerly wanted pursue my higher education. Hence, I started a full-time PhD project at the Department of Medical Epidemiology and Biostatistics at Karolinska Institute year 2003. My PhD project was within the field of cancer epidemiology investigating etiological aspects of gastroesophageal cancers. After finishing my PhD studies, I continued as a postdoctoral researcher at the Clinical Epidemiology Unit (KEP), the Department of Medicine, Solna. Ever since I continued my work within the field of pharmacoepidemiology and cancer epidemiology. At the moment I am working as senior researcher and team leader for the research area “Cancer and drugs” at the Centre for Pharmacoepidemiology (CPE), where I am responsible for various projects concerning cancer treatments and those with cancer as the possible side effect of drugs. I am involved in several ongoing international collaborative projects, mostly with Nordic countries. I have also active projects in Iran. Currently we are investigating risk factors for adverse pregnancy outcomes in northern Iran. I really enjoy working as researcher. I believe that, although it is a small piece of the puzzle, answering unresolved questions about risk factors concerning different diseases and possible side effects of drugs is helpful for both patients and clinicians. I prefer to spend my free time with my family.
My research interests are in analytical pharmacoepidemiology mainly cancer pharmacoepidemiology and etiology of some immune-mediated diseases such as multiple sclerosis using methods including examination of associations with comorbidity, including with cancer and pharmacological treatments. I am trained as cancer epidemiologist and have been involved in pharmacoepidemiological projects since 2007.
I have been involved in several national and international pharmacoepidemiological research projects using health registries and clinical databases. My ongoing projects in the field of pharmacoepidemiological concern possible risk of cancer associated with some pharmacological treatments of diabetes, possible adverse effects of newly approved drugs for lung cancer and chronic Idiopathic thrombocytopenic purpura.